Navigation Links
Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat

Research shows that an outpatient, nonsurgical treatment for a benign bone tumor called osteoid osteoma both destroys the tumor// and eliminates debilitating pain. The study showed that the treatment ended patients’ pain immediately, with no post-procedure complications. This nonsurgical technique — radiofrequency ablation — heats and destroys the nerve endings in the tumor that were causing pain. It also preserves the patient’s healthy bone, prevents major surgery and eliminates the need for lengthy rehabilitation and recovery. The interventional radiologist can visualize the tumor with CT and insert the needle into the correct area while monitoring the heat, thereby ensuring that the entire tumor is destroyed and will not grow back.

“Our research showed the interventional treatment’s success rate is as good as surgery’s, but without the risk. Plus, almost all of our patients walked out of the hospital within hours of the procedure pain-free,” says interventional radiologist Eran Hayeems, M.D., University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada. This treatment is available throughout the United States, is FDA-approved, and is covered by most insurance providers.

Often, lesions are deep inside the bone and not readily visible on the surface to a surgeon. Therefore surgeons must remove a wider area around the tumor, and still may not succeed in getting the entire tumor. For example, if a typical lesion is under 1 cm a surgeon may need to remove up to 5 cm of surrounding bone. This can sometimes result in bone grafting in order to prevent future bone fractures. The surgery can also require up to six months of rehabilitation. However, using CT imaging an interventional radiologist can pinpoint the precise location of the lesion and deliver a targeted treatment directly to the site, destroying the tumor inside the bone while leaving the remaining healthy bone intact. Radiofrequency ablation, performed by interventional radiologists on an outpatient basis, relieves pain immediately without requiring patient rehabilitation.

“Radiofrequency ablation allows otherwise healthy patients to avoid an invasive operation, get immediate pain relief, and get back to their lives right away,” added Hayeems. “Because we can visualize the tumor, an interventional radiologist can ensure that we get it all, so it won’t grow back. Interventional radiology should be the first-line standard treatment for osteoid osteomas.”

About the Technique
In radiofrequency ablation (RFA), heat is delivered directly into the tumor via a probe that is inserted through the skin using CT, MR and/or ultrasound imaging for guidance. From the tip of the needle, radiofrequency energy is transmitted into the targeted tissue where it produces heat and kills the tumor. RFA is a nonsurgical, localized treatment that spares healthy tissue without any systemic side effects. RFA can be performed without affecting the patient’s overall health and most people can resume their usual activities in a few days.

About Osteoid Osteoma
Osteoid osteomas are relatively rare benign bone tumors that affect mainly young people (teens to 20’s) who are otherwise healthy. They are three times more common in males than females. These bone lesions primarily occur in the long bones of the leg; but, they can also occur in the bones of the arms and spine. The lesions can result in growth deformities if located in long bones, or scoliosis if in the spine. If left untreated the tumors do heal over time, however it takes an average of five to six years and up to 10 years for that to occur. Typically, the pain is sharp and worse at night, but responds well to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs). These medications, however, can cause side effects such as stomach ulcers and intestinal bleeding. For patients who require intervention, surgery has been the historical treatment.

Source-Nwswise
SRM
'"/>




Related medicine news :

1. Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors
2. Outpatient List Falls From 41,000 To 6,000
3. Max Healthcare Launches Outpatient Health Plans
4. Outpatient Cancer Care Impressive in British Columbia
5. Advances in Treatment of Cataracts
6. Recommendations for Treatment of Blood Pressue
7. Treatment for Menieres disease
8. Treatment for pre-menstrual syndrome is ineffective
9. Better Treatment for obesity
10. Gene Treatment for Heart Disease
11. More People Seeking Treatment for Depression
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/7/2017)... IRVING, Texas , Oct. 6, 2017   ... industry with more than $100 billion in purchasing power, ... industry news and information. The Newsroom is ... chain and industry trends, infographics, expert bios, news releases, ... Besides having access to a wealth of resources at ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
Breaking Medicine Technology: